Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
31-45 of 2945 results
Personal Genome Diagnostics wins NCI contract to devlop novel diagnostic for immuno-oncology drugs
By MDBR Staff Writer
Personal Genome Diagnostics (PGDx) has secured an SBIR contract from the National Cancer Institute (NCI) to develop a novel diagnostic for immuno-oncology drugs.
Diagnostics > In Vitro Diagnostics > News
GenePOC announces product launch in Europe and Middle East
GenePOC, a member of the Debiopharm Group, has announced that it has started the commercialization of its first two CE-IVD marked tests, GenePOC CDiff and GenePOC GBS assays on the revogene platform that recently obtained CE-IVD marking.
Diagnostics > In Vitro Diagnostics > News
Grifols acquires Hologic’s blood screening unit for $1.85bn
By MDBR Staff Writer
Healthcare firm Grifols has completed the acquisition of Hologic’s blood screening business for around $1.85bn.
Diagnostics > In Vitro Diagnostics > News
Ampersand Capital Partners and 1315 capital to acquire Genoptix
Ampersand Capital Partners and 1315 Capital have entered into a definitive agreement to acquire the commercial laboratory of Genoptix, a Novartis company that specializes in oncology diagnostics and informatics services.
Diagnostics > In Vitro Diagnostics > News
bioMerieux recalls NucliSENS reagents over inaccurate test results
By MDBR Staff Writer
bioMerieux is recalling NucliSENS easyMAG Magnetic Silica and NucliSENS Magnetic extraction reagents due to potential inaccurate test results.
Diagnostics > In Vitro Diagnostics > News
Milenia Labs to distribute Cynvenio's ClearID breast cancer test in Mexico
Milenia Labs has agreed to distribute Cynvenio Biosystems' ClearID Breast Cancer test in Mexico.
Diagnostics > In Vitro Diagnostics > News
GenePeeks launches preconception test for combined risk of passing on genetic diseases
GenePeeks, a computational genomics company, has launched its proprietary next-generation screening platform.
Diagnostics > In Vitro Diagnostics > News
Takara Bio USA, TeselaGen Biotechnology launch new primer tool for easy design of in-fusion cloning experiments
Takara Bio USA, a wholly owned subsidiary of Takara Bio, has In Fusion cloning primer design tool, powered by TeselaGen Biotechnology, Inc. software.
Diagnostics > In Vitro Diagnostics > News
Roche introduces new haematology testing solution
By MDBR Staff Writer
Roche has entered a new era in haematology testing, with the launch of the new cobas m 511 analyser.
Diagnostics > In Vitro Diagnostics > News
Mobidiag launches new molecular extraction and PCR setup system
By MDBR Staff Writer
Finnish molecular diagnostics firm Mobidiag has introduced a molecular extraction and PCR setup system, allowing automation of multiplex PCR directly from stool samples.
Diagnostics > In Vitro Diagnostics > News
Werfen, Instrumentation Laboratory acquire Accriva Diagnostics
By MDBR Staff Writer
Medical diagnostics firm Werfen, along with its subsidiary Instrumentation Laboratory (IL), has acquired Warburg Pincus portfolio company Accriva Diagnostics.
Diagnostics > In Vitro Diagnostics > News
Partners Group, PSP Investments to buy French firm Cerba HealthCare
By MDBR Staff Writer
Partners Group, along with Canada’s Public Sector Pension Investment Board (PSP Investments), has agreed to acquire European medical laboratory services operator, Cerba HealthCare.
Diagnostics > In Vitro Diagnostics > News
FDA approves Bone Index’s second generation Bindex device to diagnose osteoporosis
By MDBR Staff Writer
European medical devices manufacturer Bone Index has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its second generation Bindex point-of-care device for diagnosing osteoporosis.
Diagnostics > In Vitro Diagnostics > News
FDA approves Roche’s Troponin T blood test for suspected heart attack
By MDBR Staff Writer
Roche has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack.
Diagnostics > In Vitro Diagnostics > News
Agilent Technologies extends collaboration on reproductive genetics
Agilent Technologies has announced that it is extending its collaboration with the Centre for Human Genetics of the University of Leuven and the University Hospital of Leuven in Belgium.
Diagnostics > In Vitro Diagnostics > News
31-45 of 2945 results